Cargando…

Stage-Dependent Impact of RIPK1 Inhibition on Atherogenesis: Dual Effects on Inflammation and Foam Cell Dynamics

Objective: Atherosclerosis is an arterial occlusive disease with hypercholesterolemia and hypertension as common risk factors. Advanced-stage stenotic plaque, which features inflammation and necrotic core formation, is the major reason for clinical intervention. Receptor interacting serine/threonine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuze, Li, Huihui, Huang, Yonghu, Chen, Hong, Rao, Haojie, Yang, Guoli, Wan, Qing, Peng, Zekun, Bertin, John, Geddes, Brad, Reilly, Michael, Tran, Jean-Luc, Wang, Miao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572953/ https://www.ncbi.nlm.nih.gov/pubmed/34760938 http://dx.doi.org/10.3389/fcvm.2021.715337

Ejemplares similares

Exosomes and Atherogenesis
por: Lin, Bingbing, et al.
Publicado: (2021)

Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis
por: Lorey, Martina B., et al.
Publicado: (2022)

The ethanol extract of Edgeworthia gardneri (Wall.) Meisn attenuates macrophage foam cell formation and atherogenesis in ApoE(−/−) mice
por: Tang, Le, et al.
Publicado: (2022)

The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice
por: Hao, Huifeng, et al.
Publicado: (2020)

Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis
por: Rasheed, Adil, et al.
Publicado: (2018)

The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach
por: Puylaert, Pauline, et al.
Publicado: (2022)

Platelets and Complement Cross-Talk in Early Atherogenesis
por: Kim, Hugh, et al.
Publicado: (2019)

Platelets in Inflammation and Atherogenesis
por: Nording, Henry M., et al.
Publicado: (2015)

Injury to the tunica media initiates atherogenesis in the presence of hyperlipidemia
por: Belhoul-Fakir, Hanane, et al.
Publicado: (2023)

The Endothelium as a Hub for Cellular Communication in Atherogenesis: Is There Directionality to the Message?
por: Howe, Kathryn L., et al.
Publicado: (2022)

Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1–RIPK3-Dependent Pathway in Mice
por: Wu, Penglong, et al.
Publicado: (2021)

Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice
por: Dai, Shen, et al.
Publicado: (2021)

MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis
por: Chen, Heming, et al.
Publicado: (2017)

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
por: Stein, Sokrates, et al.
Publicado: (2010)

Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance
por: Bellini, Rossella, et al.
Publicado: (2022)

Editorial: Implications of lipids and modified lipoproteins in atherogenesis: from mechanisms towards novel diagnostic and therapeutic targets
por: Kraler, Simon, et al.
Publicado: (2023)

Impact of Glutathione Peroxidase-1 Deficiency on Macrophage Foam Cell Formation and Proliferation: Implications for Atherogenesis
por: Cheng, Fei, et al.
Publicado: (2013)

5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Inhibits RIPK1/RIPK3-Dependent Necroptosis in THP-1-Derived Foam Cells
por: Tian, Fang, et al.
Publicado: (2016)

CYP2J2 participates in atherogenesis by mediating cell proliferation, migration and foam cell formation
por: Li, Rui, et al.
Publicado: (2017)

Comprehensive Identification of Key Genes Involved in Development of Diabetes Mellitus-Related Atherogenesis Using Weighted Gene Correlation Network Analysis
por: Huang, Qi, et al.
Publicado: (2020)

Age‐associated vascular inflammation promotes monocytosis during atherogenesis
por: Du, Wei, et al.
Publicado: (2016)

RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
por: Ke, Dan, et al.
Publicado: (2023)

Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death
por: Moriwaki, K, et al.
Publicado: (2015)

Atherogenesis: Initiating Factors
por: Waters, L. L.
Publicado: (1974)

Roles of Macrophages in Atherogenesis
por: Farahi, Lia, et al.
Publicado: (2021)

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
por: Stokman, Geurt, et al.
Publicado: (2020)

Ginkgolide B Reduces Atherogenesis and Vascular Inflammation in ApoE(−/−) Mice
por: Liu, Xiyun, et al.
Publicado: (2012)

Cellular Mechanisms of Human Atherogenesis: Focus on Chronification of Inflammation and Mitochondrial Mutations
por: Markin, Alexander M., et al.
Publicado: (2020)

MG53 Inhibits Necroptosis Through Ubiquitination-Dependent RIPK1 Degradation for Cardiac Protection Following Ischemia/Reperfusion Injury
por: Wang, Qiang, et al.
Publicado: (2022)

Targeting RIPK1,2,3 to combat inflammation
por: Bullock, Alex N., et al.
Publicado: (2015)

Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article
por: Grajeda-Iglesias, Claudia, et al.
Publicado: (2018)

Activation of NLRP3 Inflammasome Promotes Foam Cell Formation in Vascular Smooth Muscle Cells and Atherogenesis Via HMGB1
por: Wang, Rui, et al.
Publicado: (2018)

Methotrexate in Atherogenesis and Cholesterol Metabolism
por: Coomes, Eric, et al.
Publicado: (2011)

The Importance of the Plasma Membrane in Atherogenesis
por: Kotlyarov, Stanislav, et al.
Publicado: (2022)

Telomere Length: Implications for Atherogenesis
por: Yin, Hao, et al.
Publicado: (2023)

CFTR protects against vascular inflammation and atherogenesis in apolipoprotein E-deficient mice
por: Li, Zhengzhang, et al.
Publicado: (2017)

Monocyte and macrophage foam cells in diabetes-accelerated atherosclerosis
por: Cervantes, Jocelyn, et al.
Publicado: (2023)

Ca(2+)/Calmodulin-Dependent Protein Kinase II Regulation by RIPK3 Alleviates Necroptosis in Transverse Arch Constriction-Induced Heart Failure
por: Cao, Ji, et al.
Publicado: (2022)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation
por: Speir, Mary, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fdibghsjg9vidtnde9be95a3o0